mutsva wekurapa cancer yemapapu budiriro 2020

Muna 2020, kufambira mberi kwakakosha kwakaitwa mukurapa cancer yemapapu, kusanganisira kubvumidzwa kwemishonga mitsva yakanangwa uye immunotherapies, ichipa mhedzisiro dzakavandudzwa uye nzira dzemunhu dzevarwere. Kubudirira uku kwakapa sarudzo nyowani kune avo vari kurwisa cancer yemapapu, kugadzirisa kuchinjika kwemajini uye kuwedzera simba rekudzivirira remuviri kurwisa chirwere ichi.Gore Rekufambira mberi: Kiyi Nyowani yeMapapu Kurapa Kenza Yekubudirira 20202020 yakaratidza gore rakakosha mukurwisa cancer yemapapu. Ipo gore raitongwa nedenda repasi rose, vaongorori nevarapi vakaramba vachisundira miganhu yesarudzo dzekurapa. Zviitiko zvakati wandei zvinovimbisa zvakabuda, zvichipa tariro kuvarwere uye kugadziridza mamiriro ekutarisira cancer yemapapu. Shandong Baofa Cancer Research Institute yanga ichinyatsotevera kufambira mberi uku.Targeted Therapies: Precision Medicine AdvancesTargeted therapies, yakagadzirirwa kurwisa kusasimba kwakananga mumaseru egomarara, yakaona kufambira mberi kukuru muna 2020. Mishonga iyi inowanzoita kuti pave nemigumisiro mishoma pane yechinyakare chemotherapy nokuti inotarisa masero ekenza zvakanyanya.New Approvals for EGFR Mutations are common EGFR Mutations. kenza yemapapu (NSCLC). Muna 2020, itsva uye yakagadziridzwa EGFR inhibitors yakabvumidzwa, ichipa zvirinani kufambira mberi-kusununguka kupona kune varwere vane shanduko idzi. Aya matsva-generation inhibitors anowanzo kukurira nzira dzekudzivirira dzinodzikamisa kushanda kwemishonga yekutanga. Kunyanya, vamiririri vakanangana neEGFR exon 20 kuisa shanduko dzakaratidza chiitiko chinovimbisa.Semuyenzaniso, mumiririri akadaro ndiamivantamab. Tafura inotevera inoratidza mibairo yemakiriniki ekuyedzwa kweamivantamab: Yekuedza Phase Yese Response Rate (ORR) Nguva Yekupindura (DoR) Phase I 40% 11.1 mwedzi Source: FDAALK Inhibitors: Kuwedzera Kurapa OptionsAnaplastic lymphoma kinase (ALK) rearrangements ndeimwe mutyairi shanduko muNSCLC. akati wandei ALK inhibitors atovepo, uye muna 2020, tsvagiridzo yakanangana nekukunda kuramba mishonga iyi uye kugadzira mamwe ane simba inhibitors. Mishonga mitsva yemusanganiswa yakaongororwawo kuti ivandudze zvinobuda muAlK-positive lung cancer.Immunotherapy: Harnessing the Power of the Immune SystemImmunotherapy, iyo inowedzera immune system yemuviri kurwisa cancer, yakaramba iri nzvimbo huru yekufambira mberi mukurapwa kwegomarara remapapu muna 2020.Checkpoint Inhibitors in Earlier Stages,zumab inhibiluma uye petab yakachinja marapirwo ekenza yemapapu yakakwira. Muna 2020, zvidzidzo zvakaongorora kushandiswa kwemishonga iyi mukutanga kwechirwere, kusanganisira mushure mekuvhiyiwa kana musanganiswa nechemotherapy. Zvidzidzo izvi zvakaratidza kuti immunotherapy inogona kuvandudza mararamiro ehupenyu uye kuderedza dambudziko rekudzokazve kune vamwe varwere.Combination Immunotherapy RegimensVatsvakurudzi vakaongororawo kubatanidza mishonga yekudzivirira zvirwere zvakasiyana-siyana kuti iwedzere kushanda kwayo. Dual checkpoint blockade, uchishandisa marudzi maviri akasiyana e immune checkpoint inhibitors, yakaratidza vimbiso mune vamwe varwere vasina kupindura kune imwechete-agent immunotherapy. Miedzo yemakiriniki yakaramba ichinatsa nzira idzi dzemusanganiswa kuona varwere vangango batsirwa.Basa reBiomarker TestingKufambira mberi mukurapa kwakanangwa uye immunotherapies kwakaratidza kukosha kwekuwongorora kwakadzama biomarker mukenza yemapapu. Muna 2020, kwakawedzera kusimbiswa pakuyedza kwakasiyana siyana genetic mutations uye PD-L1 kutaura kutungamira sarudzo dzekurapa. Iyi nzira yemunhu inovimbisa kuti varwere vanowana kurapa kwakakodzera uye kunoshanda kwegomarara ravo chairo.Shandong Baofa Cancer Research Institute inosimbisa kukosha kwekuongororwa kwakadzama kuti uwane zvinobuda zvakanaka.Kutarisa Mberi: Mamiriro Emberi mutsva wekurapa cancer yemapapu budiriro 2020 yakagadzirira nzira yokufambira mberi kwakatowanda mumakore aizotevera. Tsvagiridzo inoenderera mberi yakanangana nekugadzira matsva anonangwa marapirwo, kuvandudza immunotherapy marongero, uye kuona zvinyorwa zvinyorwa. Chinangwa chekupedzisira ndechekugadzira marapirwo anoshanda uye emunhu anovandudza mararamiro uye hupenyu hwevarwere vese vane cancer yemapapu. Mhedziso2020 raive gore rekufambira mberi kwakanyanya mukurapa cancer yemapapu. Kubvumidzwa kwezvitsva zvakanangwa marapirwo uye immunotherapies, pamwe nekuwedzera kusimbiswa kwekuongororwa kwebiomarker, zvakashandura mamiriro ekutarisira kenza yemapapu. Kubudirira uku kunopa tariro kuvarwere nemhuri dzavo uye kunosimbisa kukosha kwekuenderera mberi nekutsvakurudza uye hutsva mukurwisana nechirwere ichi chinoparadza. Funga kushanya Shandong Baofa Cancer Research Institute's webhusaiti kuti uwane rumwe ruzivo nezve kiriniki kuyedzwa uye advanced cancer kurapwa.